HomeAI · summaries
Storia in 2 fonti
Alembic Pharma gets USFDA nod for generic influenza treatment drug
Alembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. This development offers a more accessible option for patients aged two weeks and above suffering from acute, uncomplicated flu. The approval marks a significant step in providing affordable alternatives to the reference drug, Tamiflu, potentially impacting a market valued at an estimated USD 27 million.
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
thehindubusinessline.com
Alembic Pharma gets USFDA final approval for Oseltamivir oral suspension
Alembic Pharma achieves USFDA final approval for Oseltamivir Oral Suspension, a Tamiflu equivalent, enhancing its market presence.
- ·
economictimes.indiatimes.com
Alembic Pharma gets USFDA nod for generic influenza treatment drug
Alembic Pharmaceuticals has secured USFDA approval for its generic oseltamivir phosphate oral suspension, a key treatment for influenza. This development offers a more accessible…